HopeStage
Back to all studies
CompletedNCT04284267

TMS to Support Emotion Regulation in Bipolarity

About this titleRead the official source — NCT04284267
Device studyAges 22–55United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 22 years to 55 years.

Listed locations
CharlestownSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 1, 2021
Recruitment status
Completed
Enrollment listed in the registry
56
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 22 Years to 55 Years
Official registry ID
NCT04284267
Official title
Show the full official title

Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Charlestown

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Who was this study for?

Listed age limits: 22 years to 55 years.

Want to explore more studies?

Explore studies